1. Hsieh, Ming-Ju, Lo, Yu-Sheng, Ho, Hsin-Yu, Chuang, Yi-Ching, Chen, Mu-Kuan. 2024. The Interaction between CLSPN Gene Polymorphisms and Alcohol Consumption Contributes to Oral Cancer Progression. In International journal of molecular sciences, 25, . doi:10.3390/ijms25021098. https://pubmed.ncbi.nlm.nih.gov/38256171/
2. Erkko, Hannele, Pylkäs, Katri, Karppinen, Sanna-Maria, Winqvist, Robert. . Germline alterations in the CLSPN gene in breast cancer families. In Cancer letters, 261, 93-7. doi:. https://pubmed.ncbi.nlm.nih.gov/18077083/
3. Wu, Xianxian, Sui, Zhilin, Zhang, Hongdian, Wang, Ying, Yu, Zhentao. 2020. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma. In Frontiers in oncology, 10, 554759. doi:10.3389/fonc.2020.554759. https://pubmed.ncbi.nlm.nih.gov/33042838/
4. Azenha, Diana, Hernandez-Perez, Santiago, Martin, Yuse, Freire, Raimundo, Martins, Teresa C. 2020. Implications of CLSPN Variants in Cellular Function and Susceptibility to Cancer. In Cancers, 12, . doi:10.3390/cancers12092396. https://pubmed.ncbi.nlm.nih.gov/32847043/
5. Shi, Yanlong, Wang, Yizhu, Niu, Kaiyi, Lv, Qingpeng, Zhang, Yewei. 2024. How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: A crosstalk study. In Computers in biology and medicine, 172, 108260. doi:10.1016/j.compbiomed.2024.108260. https://pubmed.ncbi.nlm.nih.gov/38492457/
6. Cai, Chao, Luo, Jiexin, Liu, Qinwei, Gu, Di, Liu, Yongda. . Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer. In Genetic testing and molecular biomarkers, 25, 131-139. doi:10.1089/gtmb.2020.0226. https://pubmed.ncbi.nlm.nih.gov/33596143/
7. Chen, Yihong, Wen, Haicheng, Li, Yin, Feng, Ziyang, Shen, Hong. 2023. A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers. In Biological procedures online, 25, 16. doi:10.1186/s12575-023-00201-6. https://pubmed.ncbi.nlm.nih.gov/37268895/
8. Jia, Yulong, Cheng, Xingbo, Liang, Wenjia, Wang, Baoya, Liu, Zhendong. 2022. CLSPN is a potential biomarker associated with poor prognosis in low-grade gliomas based on a multi-database analysis. In Current research in translational medicine, 70, 103345. doi:10.1016/j.retram.2022.103345. https://pubmed.ncbi.nlm.nih.gov/35487167/
9. Hori, Kanta, Yamada, Shuhei, Murata, Kenji, Hirohashi, Yoshihiko, Torigoe, Toshihiko. 2024. Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization. In Human vaccines & immunotherapeutics, 20, 2414542. doi:10.1080/21645515.2024.2414542. https://pubmed.ncbi.nlm.nih.gov/39539024/
10. Zhang, Jianmin, Song, Young-Han, Brannigan, Brian W, Haber, Daniel A, Bell, Daphne W. 2009. Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator Claspin. In Molecular cancer research : MCR, 7, 1510-6. doi:10.1158/1541-7786.MCR-09-0033. https://pubmed.ncbi.nlm.nih.gov/19737971/
智鼠故事 
